Global Startups Insights
Lets your startup
California, Funding News, USA Startup Funding News

BioConsortia Raises $15 Million to Expand Biological Crop Technology Worldwide

October 12, 2026
By
Loren Baker
BioConsortia Raises $15 Million to Expand Biological Crop Technology Worldwide

Agricultural technology company BioConsortia has raised $15 million in equity funding to accelerate the global commercial expansion of its biological crop products, including nitrogen-fixing seed treatments and biostimulants.

The investment came from an entity affiliated with John Pasquesi, managing member of existing investor Otter Capital. The funding will help BioConsortia expand manufacturing, regulatory operations and commercial capabilities while bringing its agricultural technologies to more markets worldwide.

BioConsortia’s key products include Always N, a biological seed treatment designed to help crops fix nitrogen and reduce reliance on synthetic fertilizers, and Zaffre, a biostimulant developed to improve crop emergence, plant establishment and yields under challenging weather conditions.

The company reported that Zaffre delivered an average yield improvement of 4.4 bushels per acre across three seasons of corn trials.

BioConsortia is also seeing growing adoption of its Always N seed treatment in New Zealand. Working with partner H&T, adoption increased from approximately 5% in 2024 to 50% in 2025, with the company projecting around 80% adoption in 2026.

The company is expanding Always N’s commercial presence across the Americas, Europe, Asia and Australia. It also has a commercial partnership with The Mosaic Company in the Americas.

The new funding will support product launches and the infrastructure needed to scale BioConsortia’s portfolio of biostimulants, biofertilizers and biological crop-protection solutions. The company is also advancing biofungicides, bionematicides and bioinsecticides through commercial partnerships and field trials.

BioConsortia develops microbial technologies for agriculture, combining microbial discovery, gene editing and field testing to create biological products designed to improve crop productivity and input efficiency.

With this funding, the company aims to accelerate commercialization and expand its global reach as farmers increasingly explore biological alternatives that can support crop performance and reduce dependence on conventional agricultural inputs.

Recommended Stories for You